MAL and prostate cancer: Our findings support the original hypothesis that methylation status of six selected index genes (HSPB1, CCND2, TIG1, DPYS, PITX2, and MAL) provides a novel, objective, and accurate prediction of death from prostate cancer in men clinically assessed as low to intermediate risk.